Stephen Hoge, M.D.

President

Stephen Hoge, M.D., serves as President of Moderna, where he oversees Research & Development, Manufacturing and Commercial for the Company's three franchises: Infectious Disease Vaccines, Individualized Neoantigen Therapy (INT), and Rare Disease Therapeutics. As President, Dr. Hoge also plays a central role in defining Moderna's corporate strategy, shaping its overall pipeline, and driving operational execution. In his more than 13 years at the Company, Dr. Hoge has led the build of most functions, including Research, Development, Medical and Commercial. He joined Moderna in 2012 from McKinsey & Company, where he was a partner in the healthcare practice. Prior to McKinsey, Dr. Hoge was a resident physician in New York City. He holds a B.A. in Neuroscience from Amherst College, and an M.D. from the University of California, San Francisco.